SCHEMBL6074064

SCHEMBL6074064

COc1ccc2c(c1)CCC(=O)N2S(C)(=O)=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRD5A1 P18405 1/20 0.49
TRIM24 O15164 1/20 0.48
NOTUM Q6P988 1/20 0.48
HSD17B10 Q99714 1/20 0.45
TP53 P04637 2/20 0.44
KMT2A Q03164 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP11B1 P15538 1/20 0.43
CYP11B2 P19099 1/20 0.43
MEN1 O00255 1/20 0.43
POLB P06746 1/20 0.42
BCL2 P10415 1/20 0.41
LMNA P02545 1/20 0.41
RYR2 Q92736 1/20 0.41
ACLY P53396 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA9 Q16790 1/20 0.40
CA14 Q9ULX7 1/20 0.40
CDC25A P30304 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6073478 0.80 TRIM24 (0.64) SRD5A1TRIM24NOTUMHSD17B10CYP1A2
SCHEMBL6606952 0.78 SRD5A1 (0.51) SRD5A1TRIM24NOTUMHSD17B10TP53
SCHEMBL6608548 0.76 SRD5A1 (0.49) SRD5A1TRIM24NOTUMHSD17B10TP53
SCHEMBL12474949 0.76 POLB (0.46) SRD5A1NOTUMKMT2AMEN1POLB
SCHEMBL6074362 0.73 ALDH1A1 (0.42) TRIM24KMT2ACYP11B1CYP11B2MEN1
SCHEMBL13531815 0.73 MEN1 (0.66) NOTUMHSD17B10TP53KMT2ACYP11B1
SCHEMBL29173745 0.72 CMA1 (0.54) KMT2AMEN1POLB
SCHEMBL6605904 0.71 SRD5A1 (0.45) SRD5A1TRIM24NOTUMHSD17B10TP53
SCHEMBL12059735 0.71 LMNA (0.56) SRD5A1TRIM24NOTUMHSD17B10TP53
SCHEMBL4223959 0.71 CHRM1 (0.52) SRD5A1TRIM24NOTUMCYP1A2CYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7119207-B2 Benzoamide piperidine containing compounds and related compounds PFIZER INC (US) 2006-10-10 US disclosed
US-20030087925-A1 Benzoamide piperidine containing compounds and related compounds PFIZER INC. 2003-05-08 US disclosed
EP-1272484-A2 BENZOAMIDE PIPERIDINE COMPOUNDS AS SUBSTANCE P ANTAGONISTS Pfizer Products Inc. (US) 2003-01-08 EP disclosed
WO-2001077100-A2 BENZOAMIDE PIPERIDINE COMPOUNDS AS SUBSTANCE P ANTAGONISTS PFIZER PRODUCTS INC. (US) 2001-10-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030087925-A1 Benzoamide piperidine containing compounds and related compounds TACR1, VIPR1, VIPR2 SRD5A1 3990/4885TRIM24 4522/4885NOTUM 4111/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.